Ironwood Pharmaceuticals (IRWD) PT Lowered to $23 at Mizuho Securities on Reduced Linzess Growth Outlook; 'Sell-Offer Overdone'
Tweet Send to a Friend
Mizuho Securities analyst Irina Koffler lowered the price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $23.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
